Aptevo Therapeutics Inc. Finance Lease, Principal Payments
Aptevo Therapeutics Inc. (APVO) reported Finance Lease, Principal Payments of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2022-11-10
- Aptevo Therapeutics Inc. finance lease, principal payments for the quarter ending 2022-09-30 was $0.00.
- Aptevo Therapeutics Inc. finance lease, principal payments for the quarter ending 2022-06-30 was $0.00.
- Aptevo Therapeutics Inc. finance lease, principal payments for the quarter ending 2022-03-31 was $0.00.
- Aptevo Therapeutics Inc. finance lease, principal payments for the quarter ending 2021-09-30 was $0.00.
- Aptevo Therapeutics Inc. finance lease, principal payments for fiscal 2019 was $0.00.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $0.00 derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $0.00 derived: sum of 4 quarters · filed 2022-03-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |